![]() |
市場調查報告書
商品編碼
2046662
尼古丁口香糖市場-全球產業規模、佔有率、趨勢、機會和預測:按產品類型、口味、含糖量、分銷管道、地區和競爭格局分類,2021-2031年Nicotine Gum Market - Global Industry Size, Share, Trends, Opportunity and Forecast, Segmented By Product Type, By Flavor (Flavored, Non-Flavored/Plain), By Sugar Content, By Distribution Channel, By Region & Competition, 2021-2031F |
||||||
全球尼古丁口香糖市場預計將從 2025 年的 17.8 億美元成長到 2031 年的 25.2 億美元,複合年成長率為 5.97%。
尼古丁口香糖是一種特定的尼古丁替代療法,它透過口腔黏膜輸送尼古丁,從而幫助戒菸並緩解戒斷症狀。該市場的擴張主要受菸草相關疾病日益普遍的推動,進而刺激了對有效戒菸方案的需求。此外,政府日益嚴格的監管,例如提高菸草製品稅和限制在公共場所吸煙,也促使消費者尋求比紙煙更安全的替代品。
| 市場概覽 | |
|---|---|
| 預測期 | 2027-2031 |
| 市場規模:2025年 | 17.8億美元 |
| 市場規模:2031年 | 25.2億美元 |
| 複合年成長率:2026-2031年 | 5.97% |
| 成長最快的細分市場 | 無醣 |
| 最大的市場 | 北美洲 |
然而,由於消費者留存率低,以及人們傾向於在沒有專業指導或藥物的情況下嘗試戒菸,該行業面臨著許多挑戰。這種對已證實有效的藥物輔助療法的抵觸情緒,嚴重阻礙了市場收入成長的潛力,並限制了整體市場滲透率。例如,根據「戒菸與健康行動」(Action on Smoking and Health)發布的2025年數據顯示,只有不到40%的成年人會使用成熟的戒菸治療方法,例如諮詢或藥物治療,這凸顯了將吸菸者轉化為尼古丁口香糖產品長期使用者的難度。
全球尼古丁口香糖市場的主要促進因素是各國政府實施嚴格的禁煙政策和稅收改革。世界各國政府都在採取積極的財政策略來減少菸草消費,導致對價格敏感的吸菸者轉向非吸菸產品。例如,英國政府在2024年10月的「秋季預算案」中恢復了菸草稅遞增機制,將手捲煙稅率提高了10%,使得購買可燃性菸草產品更加困難。這些強力的稅收措施不僅將尼古丁口香糖定位為一種醫療輔助產品,更將其視為一種控制日常尼古丁攝取量的經濟有效的選擇,從而吸引了更多注重預算的消費者進入尼古丁替代療法(NRT)市場,並維持了市場需求。
同時,消費者對尼古丁替代療法的接受度不斷提高,不僅將其視為一種醫療干預手段,更將其視為一種生活方式工具,這對市場而言也是一大利好。公共衛生部門的努力正在減少人們對戒成癮治療的偏見,從而降低了人們對使用藥物輔助治療的猶豫。這提高了戒菸者的治療順從性。根據美國醫院協會引用的2025年3月的數據,成人吸菸率將達到11.6%,為60年來的最低水平,這表明人們正顯著轉向利用現有輔助手段戒菸。這種接受度的提高對產業成長至關重要。尤其值得注意的是,世界衛生組織(WHO)報告稱,截至2025年10月,全球菸草使用者已達12億,這意味著尼古丁口香糖生產商擁有巨大且持續的潛在市場。
全球尼古丁口香糖市場擴張的主要障礙在於消費者持續使用該產品的比例較低,以及消費者越來越傾向於選擇非藥物戒菸方法。這種消費趨勢直接阻礙了收入成長,因為目標群體中有相當一部分人試圖在不借助藥物的情況下戒菸。當消費者選擇僅憑意志力戒菸時(有時被稱為「冷火雞式戒斷」),尼古丁口香糖的潛在市場會大幅萎縮,造成巨大的未開發銷售機會。尼古丁替代療法的緩慢普及限制了該行業利用全球日益增強的菸草相關風險健康意識來獲利的能力。
此外,尼古丁口香糖購買者不規律使用會削弱消費者對產品效能的認知,導致客戶維繫下降。不按建議劑量使用的吸煙者經常復吸,並且錯誤地將原因歸咎於產品本身而非自身習慣,從而降低了再次購買的意願。戒菸意願與實際使用有效戒菸工具之間的差距在全球統計數據中均有所體現。世界衛生組織(世衛組織)的數據顯示,到2025年,全球約有12億成年人仍將使用菸草製品,顯示吸菸者與有效使用戒煙輔助劑的人群之間存在顯著差距。這種對非輔助戒菸方法的持續依賴仍然是市場准入和產業永續發展的重大障礙。
D2C(直接面對消費者)和訂閱式銷售模式的快速擴張正在改變市場的流通結構,使尼古丁口香糖的銷售模式從偶爾的櫃檯購買轉向持續的數位化互動。這種模式透過自動補貨確保產品持續供應,直接解決了產業面臨的持續使用難題,並將戒煙輔助劑產品融入消費者的日常生活。這種轉變吸引了大量創業投資,擁有高客戶維繫率的數位平台與傳統零售通路的差異化日益顯著。例如,根據《富比士》2025年3月的一份報告,數位優先品牌Jones獲得了1000萬美元的A輪資金籌措,用於擴展其訂閱式尼古丁錠劑和口香糖平台,這充分展現了D2C策略的經濟潛力。
同時,基於性別和人口統計特徵的行銷策略的興起,正透過吸引那些對使用臨床戒菸產品猶豫不決的年輕電子煙用戶,擴大消費群。製造商逐漸摒棄類似藥品包裝的設計,轉而採用以生活方式為導向的品牌形象,以消除人們對電子煙使用的偏見,並迎合Z世代和千禧世代消費者的美學偏好。這項策略轉變對於應對不斷成長的從電子菸轉向口服尼古丁產品的使用者群體至關重要。根據《克萊恩紐約商業周刊》2025年3月的報告,美國疾病管制與預防中心(CDC)的數據顯示,2024年有225萬名學生使用尼古丁產品。為了因應這一趨勢,新參與企業正採用視覺吸引力強、以生活方式為導向的品牌形象,以吸引年輕群體,並擺脫戒菸產品「醫療」的刻板印象。
The global nicotine gum market is projected to expand from USD 1.78 billion in 2025 to USD 2.52 billion by 2031, demonstrating a compound annual growth rate of 5.97%. Nicotine gum, a specific nicotine replacement therapy, facilitates smoking cessation by delivering nicotine via the oral mucosa, thereby easing withdrawal symptoms. This market expansion is largely fueled by the increasing prevalence of tobacco-related diseases, which in turn drives the demand for effective quitting solutions. Furthermore, stringent government interventions, including higher taxes on tobacco products and restrictions on public smoking, are compelling consumers to seek safer alternatives to traditional cigarettes.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 1.78 Billion |
| Market Size 2031 | USD 2.52 Billion |
| CAGR 2026-2031 | 5.97% |
| Fastest Growing Segment | Sugar-Free |
| Largest Market | North America |
Nevertheless, the industry faces a substantial impediment due to limited consumer adherence and a strong inclination towards quitting smoking without professional or pharmaceutical assistance. This resistance to utilizing proven pharmaceutical aids significantly impedes the market's potential for revenue growth and limits its overall penetration. For instance, data from Action on Smoking and Health in 2025 indicated that fewer than 40% of adults attempting to quit smoking used established treatments like counseling or medication, highlighting the challenge in converting smokers into regular users of nicotine gum products.
Market Driver
A major driving force for the global nicotine gum market is the enforcement of strict government anti-smoking policies and tax reforms. Governments globally are implementing assertive fiscal strategies to reduce tobacco use, which in turn pushes price-sensitive smokers towards cessation products. For example, in October 2024, the UK government's 'Autumn Budget' reinstated the tobacco duty escalator and added a 10% increase to the specific duty on hand-rolling tobacco, making combustible products less affordable. These aggressive tax measures position nicotine gum not just as a medical aid but as a cost-effective option for managing daily nicotine intake, directing a broader group of budget-conscious consumers into the Nicotine Replacement Therapy (NRT) market and maintaining demand.
Concurrently, the market benefits considerably from the rising consumer acceptance of Nicotine Replacement Therapies as lifestyle tools rather than solely medical interventions. Public health initiatives are successfully destigmatizing addiction treatment, thereby reducing hesitance to use pharmaceutical aids and resulting in improved adherence rates among individuals attempting to quit. Data from March 2025, cited by the American Hospital Association, indicated that adult cigarette smoking had reached a 60-year low of 11.6%, showing a significant shift towards cessation supported by available aids. This enhanced acceptance is vital for industry growth, especially considering that as of October 2025, the World Health Organization reported 1.2 billion tobacco users worldwide, signifying a vast and ongoing potential market for nicotine gum manufacturers.
Market Challenge
The main obstacle to the global nicotine gum market's expansion is consumers' low adherence to the product and their widespread preference for unassisted smoking cessation methods. This consumer trend directly hinders revenue growth, as a considerable portion of the target population attempts to quit smoking without acquiring pharmaceutical aids. When individuals opt for willpower alone, often called "cold turkey," the potential market for nicotine gum shrinks significantly, leading to a large volume of untapped sales. This hesitancy to embrace nicotine replacement therapy restricts the industry's capacity to leverage increasing global health awareness concerning tobacco-related dangers.
Moreover, inconsistent use among those who do buy nicotine gum erodes the product's perceived effectiveness, resulting in lower customer retention. Smokers who do not follow the recommended dosage frequently relapse, mistakenly blaming the product instead of their usage habits, which discourages subsequent purchases. This disparity between the intention to quit and the actual use of effective tools is reflected in global statistics. The World Health Organization reported that in 2025, approximately 1.2 billion adults globally still used tobacco products, illustrating the substantial gap between active smokers and those successfully using cessation aids. This persistent reliance on unassisted methods remains a critical barrier to market entry and ongoing industry growth.
Market Trends
The rapid expansion of direct-to-consumer and subscription-based sales models is transforming market distribution, shifting the nicotine gum category from occasional over-the-counter purchases to continuous digital engagement. This approach directly tackles the industry's adherence challenge by guaranteeing ongoing product availability via automated replenishment, thereby integrating cessation aids into consumers' daily routines. This change has attracted considerable venture capital, differentiating digital platforms with high retention from conventional retail channels. For example, Forbes reported in March 2025 that the digital-first brand Jones secured a $10 million Series A funding round to scale its subscription-based nicotine lozenge and gum platform, affirming the financial promise of this direct-to-consumer strategy.
Concurrently, the rise of gender-specific and demographic-tailored marketing strategies is broadening the consumer base by appealing to younger vapers who find clinical cessation products uninviting. Manufacturers are increasingly moving away from medicinal packaging, adopting lifestyle-focused branding that destigmatizes usage and aligns with the aesthetic preferences of Gen Z and Millennial consumers. This strategic shift is crucial for engaging the growing segment of users transitioning from e-cigarettes to oral nicotine products. As per a March 2025 report by Crain's New York Business, Centers for Disease Control and Prevention data revealed that 2.25 million students used nicotine products in 2024, prompting new market players to introduce aesthetically pleasing, lifestyle-oriented branding designed to de-medicalize cessation for this younger demographic.
Report Scope
In this report, the Global Nicotine Gum Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Nicotine Gum Market.
Global Nicotine Gum Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: